Overview

Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy

Status:
Unknown status

Trial end date:
2019-09-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Warfarin Anticoagulation are effective and safe in Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients with Hypersplenism after Laparoscopic Splenectomy.

Phase:

Phase 4

Details

Lead Sponsor:

Yangzhou University

Treatments:

Aspirin
Calcium heparin
Dalteparin
Dipyridamole
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin
Warfarin